Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
复制标题
DOI:
10.1186/s12885-020-07088-6
复制
发表时间:
2020-06-22
期刊:
影响因子:
3.8
通讯作者:
Gao, Ya-yue
中科院分区:
文献类型:
--
作者:
Guo, Chao;Ju, Qian-qian;Gao, Ya-yue
Background: HOXA family genes were crucial transcription factors involving cell proliferation and apoptosis. While few studies have focused on HOXA10 in AML. We aimed to investigate the prognostic significance of HOXA10.Methods: We downloaded datasets from GEO and BeatAML database, to compare HOXA expression level between AML patients and controls. Kaplan-Meier curves were used to estimate the impact of HOXA10 expression on AML survival. The differentially expressed genes, miRNAs, lncRNAs and methylated regions between HOXA10-high and -low groups were obtained using R (version 3.6.0). Accordingly, the gene set enrichment analysis (GSEA) was accomplished using MSigDB database. Moreover, the regulatory TFs/microRNAs/lncRNAs of HOXA10 were identified. A LASSO-Cox model fitted OS to clinical and HOXA10-associated genetic variables by glmnet package.Results: HOXA10 was overexpressed in AML patients than that in controls. The HOXA10-high group is significantly associated with shorter OS and DFS. A total of 1219 DEGs, 131 DEmiRs, 282 DElncRs were identified to be associated with HOXA10. GSEA revealed that 12 suppressed and 3 activated pathways in HOXA10-high group. Furthermore, the integrated regulatory network targeting HOXA10 was established. The LASSO-Cox model fitted OS to AML-survival risk scores, which included age, race, molecular risk, expression of IKZF2/LINC00649/LINC00839/ FENDRR and has-miR-424-5p. The time dependent ROC indicated a satisfying AUC (1-year AUC 0.839, 3-year AUC 0.871 and 5-year AUC 0.813).Conclusions: Our study identified HOXA10 overexpression as an adverse prognostic factor for AML. The LASSOCOX regression analysis revealed novel prediction model of OS with superior diagnostic utility.